# Astrana Health, Inc.: filings

ASTH · Nasdaq · CIK 1083446 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asth.md) · [Financials](/companies/asth/financials.md) · [Filings](/companies/asth/filings.md) · [Insiders](/companies/asth/insiders.md)

## Reports and events: 370 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 365, 8-K 222, 10-Q 52, 4/A 47, 3 36, SC 13D/A 21, 10-K 18, CORRESP 18, UPLOAD 17, 8-K/A 16, 5 13, DEF 14A 13, D 10, 10-Q/A 9, SC 13D 9, NT 10-K 8, S-8 8, 3/A 7, NT 10-Q 6, SC 13G/A 6, DEFA14A 5, EFFECT 5, SCHEDULE 13G/A 5, 10-K/A 4, ARS 4, PRE 14A 4, S-3ASR 4, 424B3 3, 425 3, 5/A 3, S-1/A 3, S-3 3, S-4/A 3, 8-A12B 2, NTN 10Q 2, SC 13G 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, 10-QT 1, 424B7 1, CERT 1, DEF 14C 1, RW 1, S-1 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 08:05 ET | [8-K](/filings/0001104659-26-109822.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-109822 |
| 2026-09-23 | 07:30 ET | [8-K](/filings/0001104659-26-109813.md) | 1.05 Material cybersecurity incident | 0001104659-26-109813 |
| 2026-09-15 | 08:45 ET | [8-K](/filings/0001104659-26-107730.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-107730 |
| 2026-08-10 | 17:03 ET | [10-Q](/filings/0001193125-26-342631.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342631 |
| 2026-08-06 | 16:11 ET | [8-K](/filings/0001104659-26-092003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-092003 |
| 2026-07-13 | 08:05 ET | [8-K](/filings/0001104659-26-082892.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-082892 |
| 2026-07-01 | 16:15 ET | [8-K](/filings/0001104659-26-079874.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-079874 |
| 2026-06-10 | 16:15 ET | [8-K](/filings/0001104659-26-072343.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-072343 |
| 2026-05-12 | 06:06 ET | [8-K](/filings/0001104659-26-058922.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-058922 |
| 2026-05-12 | 06:03 ET | [8-K](/filings/0001104659-26-058914.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-058914 |
| 2026-05-08 | 06:01 ET | [10-Q](/filings/0001193125-26-213157.md) | Quarterly report, period 2026-03-31 | 0001193125-26-213157 |
| 2026-05-07 | 16:12 ET | [8-K](/filings/0001104659-26-057134.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-057134 |
| 2026-04-17 | 06:01 ET | [DEF 14A](/filings/0001104659-26-044536.md) | Proxy statement, period 2026-06-10 | 0001104659-26-044536 |
| 2026-03-30 | 17:33 ET | [8-K](/filings/0001104659-26-036862.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-036862 |
| 2026-03-12 | 08:11 ET | [10-K](/filings/0001193125-26-103128.md) | Annual report, period 2025-12-31 | 0001193125-26-103128 |
| 2026-03-04 | 07:30 ET | [8-K](/filings/0001104659-26-023176.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-023176 |
| 2026-03-02 | 07:11 ET | [8-K](/filings/0001104659-26-021893.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-021893 |
| 2026-01-12 | 16:06 ET | [8-K](/filings/0001104659-26-002866.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002866 |
| 2025-11-10 | 16:28 ET | [10-Q](/filings/0001193125-25-274359.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274359 |
| 2025-11-06 | 16:19 ET | [8-K](/filings/0001104659-25-107754.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-107754 |
| 2025-09-11 | 07:20 ET | [8-K/A](/filings/0001104659-25-089230.md) | 9.01 Financial statements and exhibits | 0001104659-25-089230 |
| 2025-08-07 | 17:15 ET | [10-Q](/filings/0000950170-25-105242.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105242 |
| 2025-08-07 | 16:14 ET | [8-K](/filings/0001104659-25-075194.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-075194 |
| 2025-07-02 | 07:05 ET | [8-K](/filings/0001104659-25-065009.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-065009 |
| 2025-06-11 | 16:15 ET | [8-K](/filings/0001104659-25-058542.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-058542 |
| 2025-06-04 | 06:03 ET | [8-K](/filings/0001104659-25-056164.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-056164 |
| 2025-05-13 | 16:15 ET | [8-K](/filings/0001104659-25-047838.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-047838 |
| 2025-05-09 | 17:02 ET | [10-Q](/filings/0000950170-25-068198.md) | Quarterly report, period 2025-03-31 | 0000950170-25-068198 |
| 2025-05-08 | 16:15 ET | [8-K](/filings/0001104659-25-046125.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-046125 |
| 2025-04-25 | 16:15 ET | [DEF 14A](/filings/0001104659-25-039438.md) | Proxy statement, period 2025-06-11 | 0001104659-25-039438 |
| 2025-03-28 | 06:15 ET | [8-K](/filings/0001104659-25-028969.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-028969 |
| 2025-03-14 | 08:00 ET | [10-K](/filings/0000950170-25-039122.md) | Annual report, period 2024-12-31 | 0000950170-25-039122 |
| 2025-03-14 | 07:47 ET | [8-K/A](/filings/0001104659-25-023741.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-023741 |
| 2025-03-10 | 08:00 ET | [8-K](/filings/0001104659-25-021981.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-021981 |
| 2025-03-03 | 08:00 ET | [8-K](/filings/0001104659-25-019499.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-019499 |
| 2025-02-27 | 16:34 ET | [8-K](/filings/0001104659-25-018268.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-018268 |
| 2025-02-27 | 16:09 ET | [8-K](/filings/0001104659-25-018221.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-018221 |
| 2025-02-18 | 21:45 ET | [SCHEDULE 13D/A](/filings/0001104659-25-014908.md) | Ownership report, active investor, amended | 0001104659-25-014908 |
| 2025-01-22 | 19:38 ET | [SCHEDULE 13D/A](/filings/0001104659-25-005340.md) | Ownership report, active investor, amended | 0001104659-25-005340 |
| 2025-01-21 | 08:00 ET | [8-K](/filings/0001104659-25-004739.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-004739 |
| 2025-01-14 | 08:00 ET | [8-K](/filings/0001104659-25-003293.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-003293 |
| 2024-11-14 | 08:20 ET | [8-K](/filings/0001104659-24-118357.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-118357 |
| 2024-11-12 | 16:30 ET | [8-K](/filings/0001104659-24-116826.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-116826 |
| 2024-11-12 | 14:22 ET | [10-Q](/filings/0000950170-24-125133.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125133 |
| 2024-11-08 | 17:19 ET | [8-K](/filings/0001104659-24-115969.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-115969 |
| 2024-11-08 | 08:06 ET | [8-K](/filings/0001104659-24-115610.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-115610 |
| 2024-11-07 | 17:14 ET | [8-K](/filings/0001104659-24-115381.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115381 |
| 2024-10-07 | 09:15 ET | [8-K](/filings/0001104659-24-106504.md) | 8.01 Other events | 0001104659-24-106504 |
| 2024-09-04 | 18:13 ET | [8-K](/filings/0001104659-24-096952.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-096952 |
| 2024-08-09 | 18:55 ET | [10-Q](/filings/0000950170-24-094262.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094262 |

Page 1 of 8. [Older](/companies/asth/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:39 ET. No prices; not investment advice.